11:00am - 11:35am Monday, March 9

Location & Room

Orlando - Hyatt Regency
Hyatt - Orlando Ballroom L
Extra Fee

This deep dive will look at how digital technology is changing the landscape for drug company R&D.

How will R&D evolve with the development of robust evidence around digital biomarkers, and deeper knowledge of therapeutic response, disease progression, and subpopulations with continuous monitoring? How will the knowledge created through the deployment of digital tools (wearables, apps, sensors) change the design and management of clinical trials?

Speakers will tackle these topics head-on as well as digital health’s impact on therapy and pipeline management.

Executive Director,
Digital Medicine Society
Vice President of Digital Health and Innovation,
Amgen, Inc.
Director, Payer and Life Sciences,
Senior Director, Digital Medicine,
Otsuka Pharma